If you liked this article you might like

EQT Midstream Partners, AbbVie, Blackstone Group: 'Mad Money' Lightning Round
Here's Why You Should Hope for Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)
2 Biotech Pullback Targets
Neurocrine Biosciences Snags U.S. Approval for Movement Disorder Drug